StopDownOpen the app

Funding · Healthcare & Life Sciences

OSSO raises seed funding for orthopaedic expansion

By ·

Date
Company
OSSO
What it does
Orthopaedic care provider
Kind
Funding
Amount
₹4 Cr
Stage
seed
Founded
2024
Sector
Healthcare & Life Sciences

What they do

OSSO provides regenerative orthopaedic treatments like PRP injections and physiotherapy

What happened

The company raised ₹4 Cr in a seed round led by the Haldiram family office

Why it matters

OSSO plans to open three new centres in Gurugram by the end of 2026

The details

  • OSSO has closed a seed round raising ₹4 Cr ($443K).
  • The investment was led by the Haldiram family office.
  • Total cumulative funding for OSSO now stands at ₹6.3 Cr ($693K).
  • Previous pre-seed funding of ₹2.3 Cr was raised in March 2025.
  • Angel investors include Sahil Jindal, Aakashdeep Goyal, Parijat Sharma, and Viraj Patel.
  • Founders Kunal Kishore Dhawan, Avani Shukla, Dr Karan Raj Jaggi, and Dr Devashish Raturi are involved.
  • The company has treated over 1,000 patients as of January 2026.
  • ACL injury cases have risen over 400% in the last decade according to UnivDatos.

The bigger picture

  • Regenerative options are expanding beyond traditional surgery for bone disorders.
  • Elderly populations with bone issues and youth with sports injuries are key targets.
  • Nanoscopy is being introduced to India for advanced diagnostic capabilities.

About the business

  • OSSO specializes in regenerative orthopaedics and minimally invasive procedures.
  • Treatments include PRP injections, GFC injections, and BMAC implants.
  • The company addresses conditions like arthritis, ligament injuries, and back pain.
  • Services cover physiotherapy alongside traditional surgical interventions.
  • Innovation focuses on introducing nanoscopy to the Indian market.
  • Over 1,000 patients have been handled since operations began.
  • Target demographics include the elderly and active youth with sports injuries.

What happens next

  • OSSO plans to add three centres in Gurugram by end of 2026.

The deal

Type
Seed Round

Investors

  • Haldiram family office (lead)
  • Sahil Jindal (angel) — MD, Jindal Group
  • Aakashdeep Goyal (angel) — Partner, Culture Cap
  • Parijat Sharma (angel) — Principal, ZS Associates
  • Viraj Patel (angel) — Director, DotShot

Founders

  • Kunal Kishore Dhawan, CEO
  • Avani Shukla, Cofounder
  • Dr Karan Raj Jaggi, Cofounder
  • Dr Devashish Raturi, Cofounder

About OSSO

Product
Orthopaedic centres providing surgery, physiotherapy, sports injury care, and regenerative orthopaedics.
Customers
Patients seeking orthopaedic and musculoskeletal care.
How it makes money
It earns revenue by delivering paid medical services through its care centres.
What sets it apart
Combines orthopaedics, regenerative medicine, physiotherapy, and sports injury care in one facility.
Operations
Plans to expand its network of centres and add nanoscopy in India.

Read it as a card in the app

Same day

All startup news on 7 January 2026 →